Search the Newsreel

Stryker Corp Stock (SYK) Moved Up by 4.41% on Aug 3: What Investors Need To Know

Stryker Corp (SYK) stock rose by 4.41% on August 3, driven by a strong second-quarter earnings report that surpassed expectations in MedSurg and Neurotechnology segments. The company raised its full-year earnings guidance, citing operational efficiencies and market share gains, particularly with its Mako robotic …

Stryker Corp. stock outperforms competitors on strong trading day

Stryker Corp. (SYK) shares rose 4.76% to $341.20 on Monday, outperforming its competitors and the broader market. This gain snapped a two-day losing streak for the stock. The S&P 500 Index increased by 1.48% and the Dow Jones Industrial Average rose by 1.32% on …

Stryker Aktie: Analysten senken Kursziele nach Guidance-Enge

Stryker Aktie: Guidance-Enge sorgt für Absturz

Citizens cuts Stryker stock price target on supply chain disruptions

Citizens lowered its price target for Stryker Corp. (NYSE:SYK) from $440 to $400, while maintaining a Market Outperform rating, due to operational challenges including a cyberattack and supply chain disruptions. Despite these issues, Stryker raised its fiscal 2026 organic growth and EPS guidance, and …

Solventum (SOLV) Appoints Neil Zieselman As New Chief Accounting Officer

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Solventum (NYSE:SOLV) has appointed Neil Zieselman as Senior Vice President, Controller, and Chief Accounting …

A Quick Look at Today's Ratings for Stryker Corp(SYK.US), With a Forecast Between $350 to $420

This article provides a quick overview of analyst ratings for Stryker Corp (SYK.US), showing a price forecast ranging from $350 to $420. It includes specific analyst recommendations and their respective target prices, alongside a summary of the company's recent stock performance.

Stryker (SYK) Could Be 16% Below Fair Value On Its Latest Results

Stryker Aktie: 6,43-Prozent-Einbruch trotz Prognose-Anhebung

Is Stryker (SYK) Undervalued As Earnings Trigger A Fresh Valuation Question?

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Stryker (SYK) is back in focus after its second quarter 2026 earnings, reporting sales of US$6.59b and net income of US$1.28b, alongside a …

STRYKER CORP : PIPER SANDLER CUTS TARGET PRICE TO $390 FROM $420

Piper Sandler has reduced its target price for Stryker Corp (NYSE: SYK) shares from $420 to $390. This adjustment was reported by Reuters. The news indicates a revised outlook from the financial firm regarding the medical technology company.

How Strong Q2 Earnings, Raised Guidance and Cyber Recovery Will Impact Stryker (SYK) Investors

Stryker Corporation's recently reported Q2 2026 results showed sales rising to US$6,589 million and net income to US$1,276 million, with both basic and diluted EPS from continuing operations increasing compared with the prior year period. Management also highlighted 9% organic sales growth, recovery progress …

Price to earnings forward of Andrews Sykes Group plc – LSE:ASY

Jefferies Adjusts Price Target on Stryker to $440 From $455, Maintains Buy Rating

Jefferies has adjusted its price target for Stryker (NYSE: SYK) to $440, down from the previous $455, while reiterating a Buy rating on the stock. This revision suggests a continued positive outlook for the company despite the slight reduction in the target price.

Stryker Aktie: Guidance-Enttäuschung trotz Gewinnsprung

¿Han cambiado los sólidos resultados del segundo trimestre, la revisión al alza de las previsiones y la recuperación del sector cibernético el panorama de inversión de Stryker (SYK)?

Stryker Aktie kaufen oder verkaufen? Analyse & Prognose 2026

Haben die starken Ergebnisse im zweiten Quartal, die angehobene Prognose und die Erholung im Cyberbereich das Anlage-Narrativ von Stryker (SYK) gerade verändert?

Stryker (SYK) Stock Drop Sharpens Focus On Margin Strength And Valuation

Did Strong Q2 Earnings, Raised Guidance, and Cyber Recovery Just Shift Stryker's (SYK) Investment Narrative?

SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion

SYK Q2 Deep Dive: Supply Chain Disruptions Weigh on Growth Outlook Despite Margin Expansion Medical technology company Stryker (NYSE:SYK) met Wall Street's revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-GAAP profit of $3.69 per share …

Stryker Q2 Earnings Call Highlights

Key Points Interested in Stryker Corporation? Here are five stocks we like better. Stryker reported strong Q2 results, with 9% organic sales growth and adjusted EPS of $3.69, up 17.9% year over year. Both MedSurg and Neurotechnology and Orthopaedics delivered high-single-digit organic growth as …

Stryker Corp 2Q 2026: Revenue $6.59B, EPS $3.3— 10-Q Summary

Stryker Corp reported strong second-quarter 2026 results with revenue of $6.59 billion and diluted EPS of $3.3. This growth was driven by increased unit volumes across MedSurg, Neurotechnology, and Orthopaedics, leading to higher net earnings compared to the previous year. The company saw broad-based …

Stryker catching up on orders, manufacturing after cyberattack

Stryker is recovering from a March cyberattack that significantly impacted its order processing, shipping, and manufacturing. CEO Kevin Lobo stated the company has ramped up production to address a backlog of orders and expects to reach a manageable level by the end of Q3. …

Why Stryker (SYK) Shares Are Plunging Today

Why Stryker (SYK) Shares Are Plunging Today What Happened? Shares of medical technology company Stryker (NYSE:SYK) fell 7.3% in the morning session after the company reported second-quarter results that showed revenue that only met Wall Street's expectations and organic sales growth that missed forecasts. …

Apple, Stryker, Coinbase And Other Big Stocks Moving Lower In Friday’s Pre-Market Session

U.S. stock futures were higher on Friday morning, but several major stocks, including Apple (AAPL), Stryker (SYK), and Coinbase (COIN), saw declines in pre-market trading. Apple's shares fell sharply despite beating Q3 revenue and EPS estimates, due to a lower-than-expected Q4 sales forecast. Other …

Stryker nets $6.6bn revenue in Q2; highlights resilience following cyberattack

Stryker has reported Q2 revenues of $6.6bn, denoting a 9.4% rise year-over-year (YoY), with the company's CEO lauding its "significant progress" in recovering since its global operations were disrupted by an cyberattack in March. Following the results, Stryker is tweaking its 2026 outlook at …

Wolfe Research raises Stryker stock price target on strong Q2 results

Wolfe Research has increased its price target for Stryker Corporation (NYSE:SYK) to $375 from $350, maintaining an Outperform rating after the medical technology company reported strong second-quarter 2026 results. Stryker exceeded consensus estimates with 9% organic revenue growth and 18% higher earnings per share, …

Wolfe Research eleva el precio objetivo de Stryker tras sólidos resultados del segundo trimestre

Stryker (NYSE: SYK) lifts Q2 2026 earnings and margins on higher sales

Stryker Earnings: Progress in the Quarter Puts Earlier Cyberattack in Rearview Mirror

Stryker Corp (SYK) (Q2 2026) Earnings Call Highlights: Strong 9% Organic Growth and Raised ...

This article first appeared on GuruFocus. Organic Sales Growth: 9% for Q2 2026, against a double-digit comparable in Q2 2025. Adjusted EPS: $3.69, up 17.9% year-over-year. Adjusted Gross Margin: 66%, 60 basis points favorable to Q2 2025. Adjusted Operating Margin: 27.4% of sales, 170 …

Stryker Sees Strong Recovery From Earlier Suspected Iran-Related Cyberattack

Stryker, a top-tier medical markets competitor, is showing a strong recovery after an earlier suspected Iran-related cyberattack. The company continues its long record of innovation in orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. This progress has put the cyberattack in the rearview mirror, …

Stryker expects 8.3%-9.3% organic sales growth and $14.95-$15.10 adjusted EPS in 2026 as it resumes share repurchases

Earnings Call Insights: Stryker (SYK) Q2 2026 MANAGEMENT VIEW * CEO Kevin Lobo said, "Our second quarter results demonstrated the strength of our broad product portfolio and resiliency of our teams," and added, "Our recovery from the cybersecurity incident continued as we ramped overall …

Stryker Narrows Earnings Outlook as Cyberattack Challenges Goals

Stryker Corp narrowed its full-year adjusted-earnings outlook due to challenges from a March cyberattack. The medical device manufacturer needs to boost production and clear a backlog to meet its second-half growth targets. Despite the disruption, the company reported adjusted earnings of $3.69 per share, …

Stryker (SYK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

For the quarter ended June 2026, Stryker (SYK) reported revenue of $6.59 billion, up 9.4% over the same period last year. EPS came in at $3.69, compared to $3.13 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $6.56 …